| DRB HIV transcription inhibitor |

Sample solution is provided at 25 µL, 10mM.
Nature.2017 Jan 19;541(7637):417-420.
Nature.2018 Nov;563(7731):407-411.
Nature.2018 Jun 13.
Nature.2018 Jun 27.
Nature.2018 Mar 29;555(7698):673-677.
Nature.2017 Sep 7;549(7670):96-100.
Nature.2016 Apr 21;532(7599):398-401.
Science.2016 Aug 5;353(6299)594-8
Nat Nanotechnol.2017 Dec;12(12):1190-1198.
Nature Biotechnology.2017 Jun;35(6):569-576
Nat Med.2018 Sep 17.
Cell.2018 Dec 21. pii: S0092-8674(18)31561-7.
Cell.Available online 25 October 2018.
Cell.2018 Sep 27. pii: S0092-8674(18)31183-8.
Cell.2018 Jun 28;174(1):172-186.e21.
Cell.2018 Feb 22;172(5):1007-1021.e17.
Cell.2017 Nov 30;171(6):1284-1300.e21.
Cell.2017 Aug 17. pii: S0092-8674(17)30869-3.
Cell.2017 Jul 13;170(2):312-323
Nat Med.2018 Jan 29.
Nat Med.2017 Nov;23(11):1342-1351.
Cell.2017 Apr 6;169(2):286-300.
Cell.2015 Aug 27;162(5):987-1002.
Cell.2015 Feb 12;160(4):729-44.
Nature Medicine.2017 Apr;23(4):493-500.
Cancer Cell.2018 May 14;33(5):905-921.e5.
Cancer Cell.2018 Apr 9;33(4):752-769.e8.
Cancer Cell.2018 Mar 12;33(3):401-416.e8.
Cancer Cell.2017 Aug 14;32(2):253-267.e5.
Nat Methods.2018 Jul;15(7):523-526.
Cell Stem Cell.2018 May 3;22(5):769-778.e4.
Cell Stem Cell.2017 Nov 20. pii: S1934-5909(17)30375-2.Quality Control & MSDS
- View current batch:
- Purity = 99.92%
- COA (Certificate Of Analysis)
- HPLC
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
Chemical structure


DRB Dilution Calculator
calculate

DRB Molarity Calculator
calculate
| Cas No. | 53-85-0 | SDF | Download SDF |
| Synonyms | NSC 401575,Benzimidazole | ||
| Chemical Name | 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole | ||
| Canonical SMILES | O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N2C=NC3=C2C=C(Cl)C(Cl)=C3 | ||
| Formula | C12H12Cl2N2O4 | M.Wt | 319.1 |
| Solubility | ≥12.6mg/mL in DMSO | Storage | Store at -20°C |
| Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. | ||
5, 6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a transcriptional elongation inhibitor.
Cyclin-dependent kinases (CDKs) belong to a family of protein kinases involved in regulating the cell cycle, transcription, mRNA processing, and the differentiation of nerve cells.[1] They are expressed in all known eukaryotes. With cyclin, CDK shows kinase activity. CDKs are serine-threonine kinases [1].
DRB inhibited the activity of several carboxyl-terminal domain (CTD) kinases including casein kinase II, Cdk7, Cdk8, and Cdk9 with the IC50 of 4-10 μM, ~20 μM, ~20 μM, and 3 μM) [2-5]. In HeLa cells, DRB (75 μM) inhibited 60-75% of nuclear heterogeneous RNA (hnRNA) synthesis. DRB (75 μM) reduced the appearance of labeled cytoplasmic poly(A)-containing messenger RNA (mRNA) by approximately 95%. DRB inhibited the initiation of hnRNA chains, but did not directly interfere with labeling of poly(A) [6]. DRB inhibited influenza virus multiplication in the chorioallantoic membrane in vitro [7]. DRB inhibited a HeLa protein kinase whihc phosphorylated an RNA polymerase II-derived peptide [8]. DRB can also inhibit HIV transcription (IC50 = ~4 μM) by targeting elongation enhanced by the HIV-encoded transactivator Tat.
References: [1]. Zandomeni, R.O. Kinetics of inhibition by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochemistry Journal 262, 469-473 (1989).[2]. Yankulov, K.,Yamashita, K.,Roy, R., et al. The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. The Journal of Biological Chemisty 270(41), 23922-23925 (1995).[3]. Rickert, P.,Corden, J.L., and Lees, E. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18, 1093-1102 (1999).[4]. Schang, L.M. Cyclin-dependent kinases as cellular targets for antiviral drugs. Journal of Antimicrobial Chemotherapy 50, 779-792 (2002).[5] Sehgal P B, Darnell J E, Tamm I. The inhibition of DRB (5, 6-dichloro-1-β-d-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells[J]. Cell, 1976, 9(3): 473-480.[6] Tamm I, Tyrrell D A J. Influenza virus multiplication in the chorioallantoic membrane in vitro: kinetic aspects of inhibition by 5, 6-dichloro-1-β-D-ribofuranosylbenzimidazole[J]. The Journal of experimental medicine, 1954, 100(6): 541.[7] Stevens A, Maupin M K. 5, 6-Dichloro-1-β-d-ribofuranosylbenzimidazole inhibits a HeLa protein kinase that phosphorylates an RNA polymerase II-derived peptide[J]. Biochemical and biophysical research communications, 1989, 159(2): 508-515.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
发展起各种双杂交系统Fields等建立系统基础些新系统主要报道基、诱饵表达载体及猎物表达载体等做些改进其重要改进引入额外报道基广泛采用HIS3基经改造带HIS3报道基酵母细胞HIS3启表达才能缺乏组氨酸选择性培养基HIS3报道基转录表达由诱饵猎物相互作用所启数双杂交系统往往同使用两甚至三报道基其 LacZ些改造基启区相同转录激结合位点相同转录激(述Gal4蛋白)激通种双重或重选择既提高检测灵敏度减少假阳性现象其针诱饵或猎物表达载体等所作改进详述
双杂交鉴定程要经两转化工作量相特别寻找新作用蛋白质候尤其且酵母细胞转化效率比细菌要低约4数量级转化步骤双杂交技术瓶颈Bendixen等通酵母接合型引用避免两转化操作同提高双杂交效率酵母性殖程涉及两种配合类型:a接合型α接合型两种单倍体间接合(mating)能形二倍体a接合型细胞间或α接合型细胞间能接合形二倍体根据酵母性殖特点文库质粒转化α接合型酵母细胞诱饵表达载体转化a接合型细胞别铺筛选平板使细胞菌苔(lawn)再两种菌苔复印同三重筛选平板原则诱饵靶蛋白发相互作用二倍体细胞才能平板单倍体细胞或虽二倍体细胞BD融合蛋白AD融合蛋白相互作用都淘汰克隆进步通β-半乳糖苷酶力进行鉴定项改进仅简化实验操作且提高双杂交筛选效率展开
这个直接从生物秀论坛转来的。。。有点。。。你出的力也太少了点吧
词典
转录激
双语例句
1
Transcriptional activation and repression regulation in target gene by thyroid hormone receptors
甲状腺激素受体调节靶基转录激抑制作用
2
Objective: To assay the transcriptional activation effect of prohibitin in yeast two hybrid system.
目:检测抗增殖蛋白酵母双杂交系统否具转录自激作用
二、噬菌体展示技术:编码噬菌体外壳蛋白基连接单克隆抗体DNA序列噬菌体表面表达相应单抗再噬菌体柱柱若含目蛋白与相应抗体特异性结合称噬菌体展示技术技术主要用于研究蛋白质间相互作用仅高通量及简便特点具直接基、高选择性筛选复杂混合物、筛选程通适改变条件直接评价相互结合特异性等优点目前用优化噬菌体展示技术已经展示鼠两种特殊细胞系cdna文库并离皮信号传导途径信号
三、等离共振技术:表面等离共振技术(Surface Plasmon ResonanceSPR)已蛋白质相互作用研究新手段原理利用种纳米级薄膜吸附诱饵蛋白待测蛋白与诱饵蛋白结合薄膜共振性质发改变通检测便知两种蛋白结合情况SPR技术优点需标记物或染料反应程实监控测定快速且安全用于检测蛋白核酸及其物间相互作用
四、荧光能量转移技术:荧光共振能量转移(FRET )广泛用于研究间距离及其相互作用; 与荧光显微镜结合定量获取关物体内蛋白质、脂类、DNA RNA 空信息随着绿色荧光蛋白(GFP)发展FRET 荧光显微镜能实测量体细胞内态性质提种定量测量FRET效率及供体与受体间距离简单仅需使用组滤光片测量比值利用供体受体发射谱消除光谱间串扰该简单快速实定量测量FRET 效率供体与受体间距离尤其适用于基于GFP 供体受体
五、抗体与蛋白质阵列技术:蛋白芯片技术现给蛋白质组研究带新思路蛋白质组研究主要内容研究同理状态蛋白水平量变微型化集化高通量化抗体芯片非研究工具芯片发展快芯片且技术已经益熟些抗体芯片已经向临床应用发展比肿瘤标志物抗体芯片等已经应用再眼各领域
六、免疫共沉淀技术:免疫共沉淀主要用研究蛋白质与蛋白质相互作用种技术其基本原理细胞裂解液加入抗兴趣蛋白抗体孵育再加入与抗体特异结合结合于Pansobin珠金黄色葡萄球菌蛋白A(SPA)若细胞与兴趣蛋白结合目蛋白形种复合物:目蛋白—兴趣蛋白—抗兴趣蛋白抗体—SPA|PansobinSPA|Pansobin比较复合物离离经变性聚丙烯酰胺凝胶电泳复合物四组经Western blotting用抗体检测目蛋白否预测蛋白种目蛋白细胞内与兴趣蛋白结合符合体内实际情况蛋白信度高种两缺陷:两种蛋白质结合能直接结合能第三者间起桥梁作用;二必须实验前预测目蛋白选择检测抗体所若预测确实验结本身具冒险性
七、pull-down技术:蛋白质相互作用类型牢固型相互作用暂型相互作用两种牢固型相互作用亚基蛋白复合体见通免疫共沉淀(Co-IP) 、Pull-down技术或Far-western研究Pull-down技术用固相化、已标记饵蛋白或标签蛋白(物素-、PolyHis-或GST-)细胞裂解液钓与相互作用蛋白通Pull-down技术确定已知蛋白与钓蛋白或已纯化相关蛋白间相互作用关系体外传路或翻译体系检测蛋白相互作用关系
许研究者双杂交系统进行改进发展例采用假阳性显示析双筛选系统减少假阳性发;发展哺乳物双杂交系统更研究蛋白间相互作用其双筛选系统用二种同报告基(用lacZHIS3)优势vii:⑴ 用同启表达位于酵母二染色体报告基 明显减少假阳性⑵ 通营养型筛选增强筛选能力 尤其适用于较库容量选蛋白较少情况筛选
哺乳物双杂交系统Ⅷ种基水平重建转录功能基础体内析系统种兴趣蛋白与Gal4--DNA结合结构域构融合蛋白另种蛋白与单纯疱疹病毒VP16蛋白激结构域融合蛋白表达表达些融合蛋白载体与报道载体(CAT)共同转染哺乳物细胞系报道质粒含Gal4结合位点游cat基假两融合蛋白相互作用则cat报道基表达水平明显增高用系统证实P53蛋白与T抗原相互作用 酵母双杂交系统相同结且较酵母双杂交系统更快速转染48h内结并且哺乳物细胞能更模仿体内蛋白-蛋白相互作用哺乳物双杂交系统作酵母双杂交系统辅助手段图" class="ikqb_img_alink">
用酵母双杂交或是细菌双杂交?

